최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0540731 (2014-11-13) |
등록번호 | US-9974538 (2018-05-22) |
발명자 / 주소 |
|
출원인 / 주소 |
|
인용정보 | 피인용 횟수 : 42 인용 특허 : 2631 |
A staple cartridge that comprises a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body is disclosed. The staple cartridge further comprises a plurality of staples removably positioned in the staple cavities and a compressible layer releasably positioned adjacent
A staple cartridge that comprises a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body is disclosed. The staple cartridge further comprises a plurality of staples removably positioned in the staple cavities and a compressible layer releasably positioned adjacent to the cartridge body. The compressible layer comprises a plurality of compression springs.
1. A staple cartridge, comprising: a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body;a plurality of staples removably positioned in the staple cavities; anda compressible layer releasably positioned adjacent to the cartridge body, wherein the compressible lay
1. A staple cartridge, comprising: a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body;a plurality of staples removably positioned in the staple cavities; anda compressible layer releasably positioned adjacent to the cartridge body, wherein the compressible layer comprises a plurality of compression springs. 2. The staple cartridge of claim 1, wherein the compressible layer further comprises: a first portion;a second portion; andan intermediate portion between the first portion and the second portion, wherein the compression springs are dispersed throughout the intermediate portion. 3. The staple cartridge of claim 2, wherein the first portion further comprises a tissue-contacting portion, wherein the cartridge body further comprises a deck, and wherein the second portion further comprises a deck-contacting surface. 4. The staple cartridge of claim 1, wherein the compressible layer is comprised of a nonwoven material. 5. The staple cartridge of claim 1, wherein at least one of the compression springs comprises a coiled fiber. 6. The staple cartridge of claim 1, wherein the compression springs are randomly oriented in the compressible layer. 7. The staple cartridge of claim 1, wherein at least one of the compression springs comprises at least one material selected from a group consisting of polyglycolic acid, poly(lactic acid), polycaprolactone, polydioxanone, and copolymers, and combinations thereof. 8. The staple cartridge of claim 1, wherein at least one of the compression springs comprises at least one material selected from a group consisting of lyophilized polysaccharide, glycoprotein, elastin, proteoglycan, gelatin, collagen, and oxidized regenerated cellulose, and combinations thereof. 9. The staple cartridge of claim 1, wherein the compressible layer further comprises at least one therapeutic agent selected from a group consisting of fibrin, thrombin, oxidized regenerated cellulose, diclofenac, aspirin, naproxen, sulindac, hydrocortisone, triclosan, ionic silver, ampicillin, gentamicin, polymyxin B, chloramphenicol, cisplatin, mitomycin, and adriamycin, and combinations thereof. 10. A staple cartridge, comprising: a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body;a plurality of staples removably positioned in the staple cavities; anda tissue thickness compensator comprising a plurality of fibers, wherein the tissue thickness compensator is deformable from an uncompressed height to at least one compressed height, and wherein at least one of the fibers is configured to generate a restoring force when the tissue thickness compensator is deformed to the at least one compressed height,wherein at least one of the fibers comprises a compression spring. 11. A staple cartridge, comprising: a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body;a plurality of staples removably positioned in the staple cavities; anda compressible layer releasably positioned adjacent the cartridge body, wherein the compressible layer comprises: a base; anda plurality of compressible springs connected to each other by the base. 12. The staple cartridge of claim 11, wherein the compressible layer further comprises: a first portion;a second portion; andan intermediate portion between the first portion and the second portion, wherein the compressible springs are dispersed throughout the intermediate portion. 13. The staple cartridge of claim 12, wherein the first portion further comprises a tissue-contacting portion, wherein the cartridge body further comprises a deck, and wherein the second portion further comprises a deck-contacting surface. 14. The staple cartridge of claim 11, wherein the compressible layer is comprised of a woven material. 15. The staple cartridge of claim 11, wherein at least one of the compressible springs comprises a coiled fiber. 16. The staple cartridge of claim 11, wherein the compressible springs are randomly oriented in the compressible layer. 17. The staple cartridge of claim 11, wherein at least one of the compressible springs comprises at least one material selected from a group consisting of polyglycolic acid, poly(lactic acid), polycaprolactone, polydioxanone, and copolymers, and combinations thereof. 18. The staple cartridge of claim 11, wherein at least one of the compressible springs comprises at least one material selected from a group consisting of lyophilized polysaccharide, glycoprotein, elastin, proteoglycan, gelatin, collagen, and oxidized regenerated cellulose, and combinations thereof. 19. The staple cartridge of claim 11, wherein the compressible layer further comprises at least one therapeutic agent selected from a group consisting of fibrin, thrombin, oxidized regenerated cellulose, diclofenac, aspirin, naproxen, sulindac, hydrocortisone, triclosan, ionic silver, ampicillin, gentamicin, polymyxin B, chloramphenicol, cisplatin, mitomycin, and adriamycin, and combinations thereof. 20. A staple cartridge, comprising: a cartridge body, wherein a plurality of staple cavities are defined in the cartridge body;a plurality of staples removably stored in the staple cavities; anda compressible layer releasably positioned adjacent to the cartridge body, wherein the compressible layer comprises: a tissue-contacting portion;a support portion; anda plurality of compressible spring elements connected by the support portion. 21. The staple cartridge of claim 20, wherein the cartridge body further comprises a deck, and wherein the support portion further comprises a deck-contacting surface. 22. The staple cartridge of claim 20, wherein the compressible layer is comprised of a woven material. 23. The staple cartridge of claim 20, wherein at least one of the compressible spring elements comprises a coiled fiber. 24. The staple cartridge of claim 20, wherein the compressible spring elements are randomly oriented in the compressible layer. 25. The staple cartridge of claim 20, wherein at least one of the compressible spring elements comprises at least one material selected from a group consisting of polyglycolic acid, poly(lactic acid), polycaprolactone, polydioxanone, and copolymers, and combinations thereof. 26. The staple cartridge of claim 20, wherein at least one of the compressible spring elements comprises at least one material selected from a group consisting of lyophilized polysaccharide, glycoprotein, elastin, proteoglycan, gelatin, collagen, and oxidized regenerated cellulose, and combinations thereof. 27. The staple cartridge of claim 20, wherein the compressible layer further comprises at least one therapeutic agent selected from a group consisting of fibrin, thrombin, oxidized regenerated cellulose, diclofenac, aspirin, naproxen, sulindac, hydrocortisone, triclosan, ionic silver, ampicillin, gentamicin, polymyxin B, chloramphenicol, cisplatin, mitomycin, and adriamycin, and combinations thereof.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.